Primary refractory or relapsed acute myeloid leukemia is associated with a dismal
prognosis. Allogeneic stem cell transplantation is the only therapeutic option that offers …

Methods In order to analyse the impact of the conditioning regimen we retrospectively
compared the outcome of adult patients with AML in CR1 that received an ASCT from 2010 …

Outcomes of allogeneic hematopoietic cell transplantation (HCT) in patients with acute
myeloid leukemia (AML) not in remission remains poor. Several studies reported the factors …

Purpose and design The effect of HLA-identical sibling donor (ISDs) haematopoietic stem
cell transplantation (HSCT) on adults with high-risk acute lymphoblastic leukaemia (ALL) in …

Background Recent studies have shown that mutations in internal tandem duplication (ITD)
of the FLT3 gene (FLT3-ITD) influence prognosis of cytogenetically normal AML. Our …

TO THE EDITOR: We read with deep interest the recent article by Gorin et al1 describing
their retrospective registry analysis aimed at comparison of results of autologous stem cell …

Abstract 528 Acute leukemia refractory to chemotherapy is uniformly fatal without
hematopoietic cell transplantation (HCT). However, the benefit of transplantation for patients …

Objectives: To analyze overall survival (OS), leukemia-free survival (LFS), cumulative
incidence of relapse (CIR) and non-relapse mortality (NRM) of patients with B cell-acute …

Introduction There have been considerable advances in the understanding of molecular
markers in acute myeloid leukemia (AML). It is widely accepted that internal tandem …

In addition to the clinical disease status at transplantation, the cytogenetic risk at
presentation also provides critical information for predicting the prognosis or deciding the …